1992
DOI: 10.1016/0161-5890(92)90124-g
|View full text |Cite
|
Sign up to set email alerts
|

Immunodominant structures in the aminoterminal portion of human interferon α 1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

1993
1993
2007
2007

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 23 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…(16)(17)(18) (11,17,(19)(20)(21)(22) and were used as hybridoma culture supernatants containing the respective antibodies at a concentration of 5-10 mg/ml.…”
Section: Monoclonal Antibodiesmentioning
confidence: 99%
“…(16)(17)(18) (11,17,(19)(20)(21)(22) and were used as hybridoma culture supernatants containing the respective antibodies at a concentration of 5-10 mg/ml.…”
Section: Monoclonal Antibodiesmentioning
confidence: 99%
“…The hybridoma NOAL 6/66.423.2, which produces mAb 423, has been described (1,23). The hybridoma NOAL 7.51 (mAb 7.51) was derived by using the spleen ofa BALB/c mouse hyperimmunized with the N11 subfraction as a source of cells for fusion with the NSO myeloma cell line, as described (27). NOAL 7.51 was selected on the basis of strong staining of normal human tau preparations and PHF core-derived tau fragments by immunodot assay.…”
Section: Methodsmentioning
confidence: 99%
“…Monoclonal Antibodies. The following murine monoclonal antibodies were used: mAb N27 (epitope 43-53) against IFN-R2c (26), mAb NK2 (epitope 112-132) against human leukocyte IFN (27), mAb 1-36 (epitope 63-85) against human IFN-R1 (28), mAb 4F2 (epitope 113-149) against consensus IFN-R (9) and mAb III/21 against a synthetic fragment 151-165 of IFN-R1 (29). All antibodies have IFNneutralizing activity except mAb III/21, and were used as hybridoma culture supernatants containing respective antibodies at concentrations of 5-10 µg/mL.…”
Section: Methodsmentioning
confidence: 99%